Page 397 - Read Online
P. 397
Gironés et al. Age-related efficacy of treatment in metastatic NSCLC
25. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of ML, Falanga M, Ambrosio R, Gridelli C. Treating advanced non-small
lung cancer in Europe. Lung Cancer 2003;41:245-58. cell lung cancer in the elderly. Ther Adv Med Oncol 2010;2:251-60.
26. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: 34. Gironés R, Torregrosa D, Gómez-Codina J, Maestu I, Tenias
looking to the future. J Clin Oncol 2005;23:3175-85. JM, Rosell R. Prognostic impact of comorbidity in elderly lung
27. Thomas L, Doyle A, Edelman J. Lung cancer in women: cancer patients: use and comparison of two scores. Lung Cancer
emerging differences in epidemiology, biology and therapy. Chest 2011;72:108-13.
2005;128:370-81. 35. Regina Gironés, Dolores Torregrosa, Inma Maestu, José Gómez-
28. Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Codina, Jose M. Tenias, Rafael Rosell Costa . Comprehensive
Weiderpass E, Bray F. International trends in lung cancer incidence Geriatric Assessment (CGA) of elderly lung cancer patients: a single-
by histological subtype: adenocarcinoma stabilizing in men but still center experience. J Geriatr Oncol 2012;3:98-103.
increasing in women. Lung Cancer 2014;84:13-22. 36. Froesch P, Martucci F, Györik S, Dutly AE, Cafarotti S. Management
29. Suda K, Tomizawa K, Mizuuchi H, Ito S, Kitahara H, Shimamatsu S, of non-small cell lung cancer in the elderly. Eur J Intern Med
Kohno M, Yoshida T, Okamoto T, Maehara Y, Yatabe Y, Mitsudomi 2014;25:888-94.
T. Genetic and prognostic differences of non-small cell lung cancer 37. Ramalingam SS, Dahlberg SE, Langer CJ, Gray R, Belani CP, Brahmer
between elderly patients and younger counterparts. Aging Dis JR, Sandler AB, Schiller JH, Johnson DH; Eastern Cooperative
2012;3:438-43.
30. Zhang Y, Sun Y, Pan Y, Li C, Shen L, Li Y, Luo X, Ye T, Wang R, Hu H, Oncology Group. Eastern Cooperative Oncology Group. Outcomes
Li H, Wang L, Pao W, Chen H. Frequency of driver mutations in lung for elderly, advanced-stage non small-cell lung cancer patients treated
adenocarcinoma from female never-smokers varies with histologic with bevacizumab in combination with carboplatin and paclitaxel:
subtypes and age at diagnosis. Clin Cancer Res 2012;18:1947-53. analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin
31. Regina Gironés Sarrió, María Dolores Torregrosa, Pedro López, José Oncol 2008;26:60-5.
Gómez-Codina, Rafael Rosell. Smoking habits in elderly lung cancer 38. Alexa T, Lavinia A, Luca A, Miron L, Alexa ID. Incidence of
patients: still no changes in epidemiology? A single-center experience. chemotherapy discontinuation and characteristics of elderly patients
Clin Transl Oncol 2010;12:686-91. with non-small cell lung cancer treated with platinum-based doublets.
32. Meoni G, Cecere FL, Lucherini E, Di Costanzo F. Medical treatment Contemp Oncol (Pozn) 2014;18:340-3.
of advanced non-small cell lung cancer in elderly patients: a review 39. Gironés R, Torregrosa D, Gómez-Codina J, Maestu I, Tenias JM,
of the role of chemotherapy and targeted agents. J Geriatr Oncol Rosell R. Lung cancer chemotherapy decisions in older patients: the
2013;4:282-90. role of patient preference and interactions with physicians. Clin Transl
33. Maione P, Rossi A, Sacco PC, Bareschino MA, Schettino C, Ferrara Oncol 2012;14:183-9.
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ September 30, 2016 387